Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario

BACKGROUND: High-dose chemotherapy with autologous stem-cell transplantation (asct) is an accepted part of standard therapy for patients with hematologic malignancies. Usually, stem-cell mobilization uses granulocyte colony–stimulating factor (g-csf); however, some patients are not able to be mobili...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Curr Oncol
Prif Awduron: Kouroukis, C.T., Varela, N.P., Bredeson, C., Kuruvilla, J., Xenocostas, A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Multimed Inc. 2016
Pynciau:
Practice Guideline
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4974047/
https://ncbi.nlm.nih.gov/pubmed/27536190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3137
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg